EARLY Act Legislation for Breast Cancer Prevention Gains Momentum

Gail Lebovic, M.D., president of the American Society of Breast Disease


September 29, 2009 - The campaign to pass the EARLY Act and raise awareness about breast cancer in young adult women generated momentum at a recent congressional reception on Capitol Hill.

The EARLY Act would implement a national education campaign about the risks that young adult women (under 45) face from breast cancer. The bill, with $9 million per year in proposed funding for five years, would also provide assistance to young women who have the disease.

The legislation has generated widespread support both in Congress and from national organizations, including the Susan G. Komen Foundation and Breast Cancer Network of Strength (formerly Y-Me). The legislation has over 365 cosponsors in the House of Representatives and over 30 in the Senate.

Kathryn Tunstall, former chairman of the Board and currently chair of the clinical advisory panel of NeoMatrix, told the audience that her experience as a two-time breast cancer survivor had inspired her to take a leadership role at NeoMatrix. The company provides the HALO Breast Pap Test, a new, 5-minute, noninvasive test that helps determine an individual woman's risk of developing breast cancer.

As part of its support for the EARLY Act, NeoMatrix has launched a website, www.earlyactawareness.org, that educates viewers about the EARLY Act and breast cancer risk. The site provides details on the EARLY Act and the breast cancer risks faced by younger women. It also has tools for breast cancer risk assessment and prevention, including information about HALO.

Also speaking at the Congressional Reception, which was organized by the nonprofit Tigerlily Foundation and cosponsored by NeoMatrix, was Gail Lebovic, M.D., president of the American Society of Breast Disease.

The Capitol Hill event, which drew approximately 200 people, was held in the Rayburn building of the House of Representatives immediately before Pres. Obama’s speech to the Congress on healthcare reform. Among other speakers at the Tigerlily event were Rep. Debbie Wasserman Schultz (D.-Fla.), author of the legislation; Rep. Sue Myrick (R.-N.C.) and Rep. Jackie Speier (D.-Calif.).

For more information: www.earlyactawareness.org and www.asbd.org


Related Content

News | Mammography

Nov. 30, 2025 — At RSNA 2025, Siemens Healthineers will introduce new capabilities for its Mammomat B.brilliant ...

Time December 02, 2025
arrow
News | RSNA 2025

Dec. 2, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, will present 14 studies at RSNA ...

Time December 02, 2025
arrow
News | Women's Health

Dec. 1, 2025 — A study of data from seven outpatient facilities in the New York region found that 20-24% of all the ...

Time December 02, 2025
arrow
News | Mammography

Nov. 26, 2025 — GE HealthCare has announced it received FDA Premarket Authorization for Pristina Recon DL, an advanced ...

Time November 29, 2025
arrow
News | Ultrasound Imaging

Nov. 12, 2025 — GE HealthCare and DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc., have announced their ...

Time November 20, 2025
arrow
News | Breast Imaging

Nov. 17, 2025 — RadNet, Inc. and its wholly owned subsidiary, DeepHealth have announced results from the largest real ...

Time November 17, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Artificial Intelligence

Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...

Time November 07, 2025
arrow
News | RSNA 2025

Nov. 3, 2025 — QT Imaging Holdings has announced that its chief medical officer, Elaine luanow, MD, will host a seminar ...

Time November 04, 2025
arrow
News | Breast Imaging

Oct. 28, 2025 — QT Imaging Holdings, Inc., a medical device company focused on radiation-free imaging technology, has ...

Time October 28, 2025
arrow
Subscribe Now